Delivery Order SPE2DR25D2014-SPE2DR26FZ92J
- Not listed
- The Defense Logistics Agency awarded a $8,014.93 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city....
- This delivery order, awarded June 16, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 120 capsules of Jatenzo 237 mg at a firm fixed price of $2,263.74, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This IDC serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Jatenzo 158 mg capsules (120-count) with a ceiling value of $1,261.16. This competitive award, which was not set-aside, represents a firm fixed-price delivery order with an ultimate completion date of November 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,188.02 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,664.07 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 1, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Jatenzo 198 mg capsules (120-count units) with a ceiling value of $1,443.58. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Jatenzo 237 mg capsules (120 count) with a contract value of $2,276.50. This non-competitive, firm fixed-price delivery order is set to be completed by May 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Jatenzo 198 mg capsules (120-count units) with a contract ceiling value of $1,411.71. This firm fixed-price delivery order, with an ultimate completion date of November 28, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Jatenzo 237 mg capsules (120 count) valued at $1,640.34. This firm fixed-price delivery order, which is scheduled for completion by August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.80 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ92JDelivery Order
This delivery order, valued at $2,191.62, was awarded on December 9, 2025, to AmerisourceBergen Drug Corp for the supply of Jatenzo 237 mg capsules (120 count) under a firm fixed-price contract with the Defense Logistics Agency (DLA). The award is non-competitive and represents a child delivery order under a larger indefinite delivery contract vehicle. Performance will be completed at the prime contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills this order as a critical medical supply vendor for federal healthcare systems. The company operates under a substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the vehicle enabling the company to supply pharmaceuticals and medical products to military and federal healthcare programs globally. This particular delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible pharmaceutical procurement arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/8/25 |